Showing results (1121-1130 of 1,520) with videos related to

Sort By:
Pageof 152
Prostate Cancer and Prostatic Diseases|March 7, 2012
Long-term follow-up of prostate cancer patients treated with vaccine and definitive radiation therapyM Kamrava, A H Kesarwala, R A Madan, et al.
American Heart Journal|August 30, 2001
Minimally invasive aortic valve replacement: echocardiographic and clinical resultsS Kort, R M Applebaum, E A Grossi, et al.
Blood|May 9, 2001
A potential role for interleukin-7 in T-cell homeostasisT J Fry, E Connick, J Falloon, et al.
Cancer|March 15, 1994
Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with responseB A Pockaj, R M Sherry, J P Wei, et al.
The Journal of Infectious Diseases|January 1, 1993
2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trialM J Browne, K H Mayer, S B Chafee, et al.
Clinical Genitourinary Cancer|May 21, 2013
Phase II study of satraplatin and prednisone in patients with metastatic castration-resistant prostate cancer: a pharmacogenetic assessment of outcome and toxicityWilliam D Figg, Cindy H Chau, Ravi A Madan, et al.
Journal of Nutrition Education and Behavior|March 26, 2017
Using Skin Carotenoids to Assess Dietary Changes in Students After 1 Academic Year of Participating in the Shaping Healthy Choices ProgramLori M Beccarelli, Rachel E Scherr, Madan Dharmar, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1975
The effects of varying dialysis regimens on lymphocyte stimulationK S Hurst, L F Saldanha, S M Steinberg, et al.
Journal of the National Cancer Institute|January 17, 1990
Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trialA F Gazdar, S M Steinberg, E K Russell, et al.
Antiviral Research|May 13, 1999
A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infectionR W Humphrey, K M Wyvill, B Y Nguyen, et al.
Pageof 152